Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Medium comprising serum replacement, IGF1, STAT3 activator and adrenal gland hormone without BFGF or rock inhibitor for producing corneal endothelial substitute cells from iPS cells and a method thereof

US Patent 12350294 · Granted Jul 8, 2025

Assignee

Inventors

View full patent text on Google Patents →